An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

Journal of Rheumatology

Volumn 44, Issue 10, 2017, Pages 1453-1457

  Bossini Castillo, Lara ^a   Campillo Davo, Diana ^a   Lopez Isac, Elena ^a   Carmona, Francisco David ^a   Simeon, Carmen P ^b   Carreira, Patricia ^c   Callejas Rubio, Jose Luis ^d   Castellvi, Ivan ^e   Fernandez Nebro, Antonio ^f   Rodriguez Rodriguez, Luis ^g   Rubio Rivas, Manel ^h   Garcia Hernandez, Francisco J ⁱ   Madronero, Ana Belen ^j   Beretta, Lorenzo ^k   Santaniello, Alessandro ^k   Lunardi, Claudio ^l   Airo, Paolo ^m   Hoffmann Vold, Anna Maria ⁿ   Kreuter, Alexander ^o   Riemekasten, Gabriela ^p   Witte, Torsten ^q   Hunzelmann, Nicolas ^r   Vonk, Madelon C ^s   Voskuyl, Alexandre E ^t   De Vries Bouwstra, J ^u   Shiels, Paul ^v   Herrick, Ariane ^w   Worthington, Jane ^w   Radstake, Timothy R D J ^x   Martin, Javier ^a   more..

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f Hospital Carlos Haya   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j Hospital General San Jorge   (Spain)

^k UNIVERSITY OF MILAN   (Italy)

^l UNIVERSITY OF VERONA   (Italy)

^m Servizio di Reumatologia Ed Immunologia Clinica Spedali Civili   (Italy)

ⁿ OSLO UNIVERSITY HOSPITAL   (Norway)

^o RUHR UNIVERSITY BOCHUM   (Germany)

^p UNIVERSITY OF LÜBECK   (Germany)

^q HANNOVER MEDICAL SCHOOL   (Germany)

^r UNIVERSITY OF COLOGNE   (Germany)

^s RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^t VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^u LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^v UNIVERSITY OF GLASGOW   (United Kingdom)

^w UNIVERSITY OF MANCHESTER   (United Kingdom)

^x UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

Mif rs755622; Pulmonary arterial hypertension; Systemic sclerosis

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; ISOMERASE; MIF PROTEIN, HUMAN;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MIF GENE; PRIORITY JOURNAL; PROMOTER REGION; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; ALLELE; COMPLICATION; DIFFUSE SCLERODERMA; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE;

ALLELES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SCLERODERMA, DIFFUSE;

EID: 85030311387     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.161369     Document Type: Article

References (26)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
2. Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol 2014;66:1967-78.
3. Bossini-Castillo L, Lopez-Isac E, Mayes MD, Martin J. Genetics of systemic sclerosis. Semin Immunopathol 2015;37:443-51.
4. Bossini-Castillo L, Lopez-Isac E, Martin J. Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun 2015;64:53-65.
5. Stosic-Grujicic S, Stojanovic I, Nicoletti F. MIF in autoimmunity and novel therapeutic approaches. Autoimmun Rev 2009;8:244-9.
6. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791-800.
7. Bossini-Castillo L, Simeon CP, Beretta L, Vonk MC, Callejas-Rubio JL, Espinosa G, et al; Spanish Scleroderma Group. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. Rheumatology 2011;50:1976-81.
8. Wu SP, Leng L, Feng Z, Liu N, Zhao H, McDonald C, et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum 2006;54:3661-9.
9. Sreih A, Ezzeddine R, Leng L, LaChance A, Yu G, Mizue Y, et al. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum 2011;63:3942-51.
10. Zhong XB, Leng L, Beitin A, Chen R, McDonald C, Hsiao B, et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res 2005;33:e121.
11. Bargagli E, Olivieri C, Nikiforakis N, Cintorino M, Magi B, Perari MG, et al. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis. Respir Physiol Neurobiol 2009;167:261-7.
12. Zhang Y, Talwar A, Tsang D, Bruchfeld A, Sadoughi A, Hu M, et al. Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension. Mol Med 2012;18:215-23.
13. Becker H, Willeke P, Schotte H, Domschke W, Gaubitz M. Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis. Clin Rheumatol 2008; 27:1307-11.
14. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
15. Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, et al; Scleroderma Foundation and Pulmonary Hypertension Association. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 2013;65:3194-201.
16. Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, et al. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Semin Arthritis Rheum 2014;44:55-62.
17. Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet 2014;94:47-61.
18. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-63.
19. Simeon-Aznar CP, Fonollosa-Pla V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, et al. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum 2012;41:789-800.
20. Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 2011; 63:783-94.
21. Selvi E, Tripodi SA, Catenaccio M, Lorenzini S, Chindamo D, Manganelli S, et al. Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis. Ann Rheum Dis 2003;62:460-4.
22. Le Hiress M, Tu L, Ricard N, Phan C, Thuillet R, Fadel E, et al. Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor/CD74 complex. Am J Respir Crit Care Med 2015;192:983-97.
23. Kasama T, Ohtsuka K, Sato M, Takahashi R, Wakabayashi K, Kobayashi K. Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases. Arthritis 2010;2010:106202.
24. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009;104:236-44.
25. Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004;138:540-6.
26. Cenit MC, Simeon CP, Vonk MC, Callejas-Rubio JL, Espinosa G, Carreira P, et al. Influence of the IL6 gene in susceptibility to systemic sclerosis. J Rheumatol 2012;39:2294-302.